Male Infertility Market - Top Companies and Manufacturers

Companies Dominating the Male Infertility Landscape

The male infertility market is competitive with global, regional, and local players vying for market share. Key market players in national and global markets are focusing on acquisitions, research and development, and product launches for early fertility care to increase their market revenue shares.

Some of the key players in the male infertility market are:

Andrology Solutions

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

Merck
Vitrolife Group
HalotechDNA
Bayer AG
SCSA Diagnostics, Inc.
Examen
Posterity Health
ExSeed Health
Carrot Fertility

Reproductive Medicine Associates

Browse Key Market Insights with Data Illustration:

Male Infertility Market Size & Share | Growth Report 2037

In the News

In July 2024, LEGACY secured USD 7.5 million to make sperm testing and storage more accessible to all clients, especially military clients.
In June 2024, Ferring Health and Posterity launched a new male fertility program on Ferring’s Fertility Out Loud platform enabling men to understand their fertility status.
In June 2023, University of Alberta found unique protein biomarkers that can indicate whether surgery will work and offer non invasive diagnosis to couples.
In June 2021, Nova IVF Fertility and Southend Fertility announced a strategic partnership to increase their presence in Delhi, India.

Frequently Asked Questions (FAQ)

The male infertility market was valued at USD 4.4 billion in 2024 and is poised to register a profitable CAGR of 4.8% during the forecast period, i.e., 2025-2037.

The male infertility market was valued at USD 4.4 billion in 2024 and is estimated to reach USD 8.4 billion by 2037 at a CAGR of 4.8% during the forecast period, i.e., 2025-2037. In 2025, the global market is projected to reach USD 4.6 billion.

The major players in the market are Andrology Solutions, Merck, Vitrolife Group, HalotechDNA, Bayer AG, SCSA Diagnostics, Inc., Examen, Carrot Fertility, and others.

The hospital pharmacies segment is projected to capture the largest revenue share with a 31% market share by 2037.

North America is estimated to provide the largest revenue opportunities by 2037. The market in North America was estimated at USD 1.8 billion in 2024.

Male Infertility Market - Top Companies and Manufacturers

Companies Dominating the Male Infertility Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the male infertility market?

What is the outlook for the social media crisis management services market?

Who are the major players dominating the male infertility market?

Which product segment will capture the significant market share for the male infertility sector by 2037?

Which region will provide more business opportunities for the growth of the male infertility market in the future?